MSL1
Basic information
Region (hg38): 17:40121971-40136917
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the MSL1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 12 | 12 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 12 | 0 | 0 |
Variants in MSL1
This is a list of pathogenic ClinVar variants found in the MSL1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
17-40126289-A-G | not specified | Uncertain significance (Aug 20, 2024) | ||
17-40126319-T-C | not specified | Uncertain significance (Jun 24, 2022) | ||
17-40126388-G-C | not specified | Uncertain significance (Oct 20, 2021) | ||
17-40129265-C-T | not specified | Uncertain significance (May 31, 2023) | ||
17-40129280-C-T | not specified | Uncertain significance (Jun 16, 2023) | ||
17-40129424-G-A | not specified | Uncertain significance (Mar 07, 2024) | ||
17-40129502-C-T | not specified | Uncertain significance (Feb 14, 2023) | ||
17-40129515-A-T | not specified | Uncertain significance (Oct 22, 2024) | ||
17-40129586-C-A | not specified | Uncertain significance (Oct 11, 2024) | ||
17-40131557-G-A | not specified | Uncertain significance (Oct 01, 2024) | ||
17-40133050-T-G | not specified | Uncertain significance (Aug 09, 2021) | ||
17-40133103-G-T | not specified | Uncertain significance (Feb 28, 2024) | ||
17-40133848-C-G | not specified | Uncertain significance (Jun 07, 2024) | ||
17-40133863-T-C | not specified | Uncertain significance (Jun 07, 2024) | ||
17-40134279-G-T | not specified | Uncertain significance (Aug 05, 2024) | ||
17-40134293-C-T | not specified | Uncertain significance (Jan 09, 2024) | ||
17-40134314-G-A | not specified | Uncertain significance (Nov 27, 2023) | ||
17-40134337-A-C | not specified | Uncertain significance (Jun 05, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
MSL1 | protein_coding | protein_coding | ENST00000579565 | 8 | 14492 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.999 | 0.00110 | 124476 | 0 | 1 | 124477 | 0.00000402 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.77 | 115 | 182 | 0.631 | 0.00000967 | 2247 |
Missense in Polyphen | 38 | 87.547 | 0.43405 | 1086 | ||
Synonymous | 0.448 | 64 | 68.7 | 0.931 | 0.00000360 | 665 |
Loss of Function | 4.12 | 0 | 19.8 | 0.00 | 0.00000110 | 253 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000647 | 0.0000647 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00 | 0.00 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Component of histone acetyltransferase complex responsible for the majority of histone H4 acetylation at 'Lys-16' (H4K16ac) which is implicated in the formation of higher-order chromatin structure. Greatly enhances MSL2 E3 ubiquitin ligase activity, promoting monoubiquitination of histone H2B at 'Lys-34' (H2BK34Ub). This modification in turn stimulates histone H3 methylation at 'Lys-4' (H3K4me) and 'Lys-79' (H3K79me) and leads to gene activation, including that of HOXA9 and MEIS1. In the MSL complex, acts as a scaffold to tether MSL3 and KAT8 together for enzymatic activity regulation. {ECO:0000269|PubMed:16227571, ECO:0000269|PubMed:21726816, ECO:0000269|PubMed:22547026}.;
- Pathway
- Chromatin modifying enzymes;HATs acetylate histones;Chromatin organization
(Consensus)
Recessive Scores
- pRec
- 0.118
Intolerance Scores
- loftool
- 0.236
- rvis_EVS
- -0.05
- rvis_percentile_EVS
- 49.76
Haploinsufficiency Scores
- pHI
- hipred
- Y
- hipred_score
- 0.662
- ghis
- 0.610
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.803
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Msl1
- Phenotype
Gene ontology
- Biological process
- histone H4-K16 acetylation
- Cellular component
- nucleoplasm;MSL complex
- Molecular function
- chromatin binding